269 related articles for article (PubMed ID: 16469486)
61. Totally implantable central venous access devices in adult oncological patients.
Florio G; Del Papa M; Mari A; Carnì D
Chir Ital; 2008; 60(5):697-702. PubMed ID: 19062492
[TBL] [Abstract][Full Text] [Related]
62. [Long-term central venous access in oncology. Review of a caseload of 750 cases].
Bertoglio S; Meszsaros P; Disomma C; Moresco L; Cafiero F; Gipponi M; Percivale P
Minerva Chir; 1996 Jun; 51(6):427-31. PubMed ID: 8992390
[TBL] [Abstract][Full Text] [Related]
63. Cathlink 20: a subcutaneous implanted central venous access device used in children with sickle cell disease on long-term erythrocytapheresis--a report of low complication rates.
Raj A; Bertolone S; Bond S; Burnett D; Denker A
Pediatr Blood Cancer; 2005 Jun; 44(7):669-72. PubMed ID: 15700248
[TBL] [Abstract][Full Text] [Related]
64. Use of totally implantable central venous access port via the basilic vein in patients with thoracic malignancies.
Sonobe M; Chen F; Fujinaga T; Sato K; Shoji T; Sakai H; Miyahara R; Bando T; Okubo K; Hirata T; Date H
Int J Clin Oncol; 2009 Jun; 14(3):208-12. PubMed ID: 19593611
[TBL] [Abstract][Full Text] [Related]
65. Experience with an implantable venous access system for chemotherapy.
Pettengell R; Davies AJ; Harvey VJ
N Z Med J; 1991 Jul; 104(915):284-5. PubMed ID: 1852329
[TBL] [Abstract][Full Text] [Related]
66. Permanent central venous access devices.
Wesley JR
Semin Pediatr Surg; 1992 Aug; 1(3):188-201. PubMed ID: 1345487
[TBL] [Abstract][Full Text] [Related]
67. Central venous access port-related complications in outpatient chemotherapy for colorectal cancer.
Inaba Y; Yamaura H; Sato Y; Najima M; Shimamoto H; Nishiofuku H; Ura T; Muro K
Jpn J Clin Oncol; 2007 Dec; 37(12):951-4. PubMed ID: 18057011
[TBL] [Abstract][Full Text] [Related]
68. Guidewire assisted cephalic vein cutdown for insertion of totally implantable access ports.
Chang HM; Hsieh HF; Hsu SD; Liao GS; Lin CH; Hsieh CB; Yu JC
J Surg Oncol; 2007 Feb; 95(2):156-7. PubMed ID: 17262733
[TBL] [Abstract][Full Text] [Related]
69. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
70. Comparison between peripherally implanted ports and externally sited catheters for long-term venous access.
Pullyblank AM; Carey PD; Pearce SZ; Tanner AG; Guillou PJ; Monson JR
Ann R Coll Surg Engl; 1994 Jan; 76(1):33-8. PubMed ID: 8117017
[TBL] [Abstract][Full Text] [Related]
71. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
[TBL] [Abstract][Full Text] [Related]
72. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
Ghayyda SN; Roland D; Cade A
J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
[TBL] [Abstract][Full Text] [Related]
73. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer.
Allen RC; Holdsworth MT; Johnson CA; Chavez CM; Heideman RL; Overturf G; Lemon D; Hunt WC; Winter SS
Pediatr Blood Cancer; 2008 Jul; 51(1):53-8. PubMed ID: 18266227
[TBL] [Abstract][Full Text] [Related]
74. High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours.
Cheong K; Perry D; Karapetis C; Koczwara B
Intern Med J; 2004 May; 34(5):234-8. PubMed ID: 15151668
[TBL] [Abstract][Full Text] [Related]
75. Risk factors for early catheter-related infections in cancer patients.
Penel N; Neu JC; Clisant S; Hoppe H; Devos P; Yazdanpanah Y
Cancer; 2007 Oct; 110(7):1586-92. PubMed ID: 17685401
[TBL] [Abstract][Full Text] [Related]
76. Less frequent catheter dressing changes decrease local cutaneous toxicity of high-dose chemotherapy in children, without increasing the rate of catheter-related infections: results of a randomised trial.
Benhamou E; Fessard E; Com-Nougué C; Beaussier PS; Nitenberg G; Tancrède C; Dodeman S; Hartmann O
Bone Marrow Transplant; 2002 Apr; 29(8):653-8. PubMed ID: 12180109
[TBL] [Abstract][Full Text] [Related]
77. Catheter-related bloodstream infections in the pediatric intensive care unit.
Newman CD
Semin Pediatr Infect Dis; 2006 Jan; 17(1):20-4. PubMed ID: 16522502
[TBL] [Abstract][Full Text] [Related]
78. Central venous catheter infections in burn patients with scheduled catheter exchange and replacement.
O'Mara MS; Reed NL; Palmieri TL; Greenhalgh DG
J Surg Res; 2007 Oct; 142(2):341-50. PubMed ID: 17631903
[TBL] [Abstract][Full Text] [Related]
79. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
[TBL] [Abstract][Full Text] [Related]
80. [Central venous access in pediatric patients. A 6-year experience].
Torramade Ribas J; Hernández Lizoáin JL; Benito Fernández C; González Fernández J; Balen Rivera E; Martínez Regueira F; Pardo Sánchez F; Cienfuegos Suárez JA
An Esp Pediatr; 1993 Mar; 38(3):251-4. PubMed ID: 8460845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
